Rayquaza & Deoxys LEGEND

HS—Undaunted · #90 · LEGEND

CARDMARKET →

€55.04

↑ 12.6% 30D

Graded

PSA 9€874.51

PSA 10€5,706

Composite

6.6

Verify externally — possibly staleEU 68% below US

Buy range€110.95 – €145.09Suspect — verify variant

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

6.6

SCORE / 10

Liquidity

8.6

Scarcity

—

Era potential

4.4

Friction

5.9

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10

PSA 9

PSA 8

Total graded

No PSA pop data on file for this card yet.

OVERVIEW

Investment summary

Rayquaza & Deoxys LEGEND (#90) from HS—Undaunted currently trades at €55.04 in the raw market. Over the past 30 days the card has appreciated +12.6%. By market value it ranks #6 of 91 in HS—Undaunted — the 95th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a top-tier ranking in HS—Undaunted alongside rising 30-day momentum frames where Rayquaza & Deoxys LEGEND sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.